These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26226924)

  • 1. Therapeutic advances in Huntington's Disease.
    Shannon KM; Fraint A
    Mov Disord; 2015 Sep; 30(11):1539-46. PubMed ID: 26226924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial and metabolic-based protective strategies in Huntington's disease: the case of creatine and coenzyme Q.
    Naia L; Ribeiro MJ; Rego AC
    Rev Neurosci; 2011 Dec; 23(1):13-28. PubMed ID: 22150069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on Huntington's disease: advances in care and emerging therapeutic options.
    Zielonka D; Mielcarek M; Landwehrmeyer GB
    Parkinsonism Relat Disord; 2015 Mar; 21(3):169-78. PubMed ID: 25572500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pridopidine for the treatment of Huntington's disease.
    Shannon KM
    Expert Opin Investig Drugs; 2016; 25(4):485-92. PubMed ID: 26881734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental therapeutics in Huntington's disease: are models useful for therapeutic trials?
    Bates GP; Hockly E
    Curr Opin Neurol; 2003 Aug; 16(4):465-70. PubMed ID: 12869804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveying the landscape of Huntington's disease mechanisms, measurements, and medicines.
    Crook ZR; Housman DE
    J Huntingtons Dis; 2013; 2(4):405-36. PubMed ID: 25062729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on Huntington's disease: from the gene to the clinic.
    Kim SD; Fung VS
    Curr Opin Neurol; 2014 Aug; 27(4):477-83. PubMed ID: 24978638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging chemotherapeutic strategies for Huntington's disease.
    Ryu H; Ferrante RJ
    Expert Opin Emerg Drugs; 2005 May; 10(2):345-63. PubMed ID: 15934871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic options for Huntington's disease.
    Grimbergen YA; Roos RA
    Curr Opin Investig Drugs; 2003 Jan; 4(1):51-4. PubMed ID: 12625029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in Huntington's disease: implications for experimental therapeutics.
    Feigin A; Zgaljardic D
    Curr Opin Neurol; 2002 Aug; 15(4):483-9. PubMed ID: 12151847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Huntington's disease: pathomechanism and therapeutic perspectives.
    Gárdián G; Vécsei L
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1485-94. PubMed ID: 15480847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Huntington's disease. Unorthodox clinical trials meld science and care.
    Couzin J
    Science; 2004 May; 304(5672):816-7. PubMed ID: 15131283
    [No Abstract]   [Full Text] [Related]  

  • 13. Energy metabolism defects in Huntington's disease and effects of coenzyme Q10.
    Koroshetz WJ; Jenkins BG; Rosen BR; Beal MF
    Ann Neurol; 1997 Feb; 41(2):160-5. PubMed ID: 9029064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trials in Huntington's disease: Interventions in early clinical development and newer methodological approaches.
    Sampaio C; Borowsky B; Reilmann R
    Mov Disord; 2014 Sep; 29(11):1419-28. PubMed ID: 25216371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translating cell therapies for neurodegenerative diseases: Huntington's disease as a model disorder.
    Rosser AE; Busse ME; Gray WP; Badin RA; Perrier AL; Wheelock V; Cozzi E; Martin UP; Salado-Manzano C; Mills LJ; Drew C; Goldman SA; Canals JM; Thompson LM
    Brain; 2022 Jun; 145(5):1584-1597. PubMed ID: 35262656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Huntington's disease: Current and future therapeutic prospects.
    Kieburtz K; Reilmann R; Olanow CW
    Mov Disord; 2018 Jul; 33(7):1033-1041. PubMed ID: 29737569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current perspectives in the treatment of Huntington's chorea].
    Kuran W
    Neurol Neurochir Pol; 2002; 36(4):757-65. PubMed ID: 12418139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging Huntington's disease (HD) brains--imagine HD trials!
    Kremer HP
    J Neurol Neurosurg Psychiatry; 2005 May; 76(5):620. PubMed ID: 15834014
    [No Abstract]   [Full Text] [Related]  

  • 19. [Molecular therapeutic strategies for Huntington's disease].
    Milewski M; Hoffman-Zacharska D; Ball J
    Postepy Biochem; 2015; 61(1):18-24. PubMed ID: 26281350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evidence-based approach in the treatment of Huntington's disease.
    Mestre TA; Ferreira JJ
    Parkinsonism Relat Disord; 2012 May; 18(4):316-20. PubMed ID: 22177624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.